✦ LIBER ✦
6113 BRAF V600E mutation and Amphiregulin (AR) immunohistochemical expression in the prediction of benefit from cetuximab plus irinotecan in KRAS wild-type metastatic colorectal cancer (mCRC) patients
✍ Scribed by Cremolini, C.; Loupakis, F.; Perrone, G.; Ruzzo, A.; Rulli, E.; Bencardino, K.; Vincenzi, B.; Salvatore, L.; Graziano, F.; Falcone, A.
- Book ID
- 121925015
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 66 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.